Lexaria Bioscience Launches Ongoing Investor Video Series to Expand Shareholder Communications Biotech Investing
Senseonics Holdings, Inc. Schedules First Quarter 2026 Earnings Release and Conference Call for May 7, 2026 at 4:30 P.M. Eastern Time Life Science Investing
Quantum-Si to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ Life Science Investing
BioVaxys Presents Further Validation of the Robust Immune Response from a Combination of MVP-S with Checkpoint Inhibitors and Low-Dose Cyclophosphamide in Ovarian Cancer Life Science Investing
Arrowhead Pharmaceuticals Receives TGA Approval of REDEMPLO® in Australia, Expanding Global Access for Patients with Familial Chylomicronemia Syndrome Life Science Investing
Axsome Therapeutics Hosts AUVELITY® FDA Approval Investor Event Featuring Expert Thought Leader Life Science Investing
Eton Pharmaceuticals relaunches HEMANGEOL® Oral Solution with Eton Cares and Exclusive Specialty Pharmacy Distribution Life Science Investing
Gilead Sciences to Present at Upcoming Second Quarter 2026 Investor Conferences Life Science Investing
Senseonics Announces Pricing of $80 Million Public Offering of Common Stock and Pre-Funded Warrants Life Science Investing
CORRECTION: Helus Pharma Partners with TARA Mind to Advance Veteran Mental Health Medical Device Investing
